Big drugmakers aren’t doing as big deals as they had, mostly doing less risky bolt-ons under $10 billion

About three-quarters of pharmaceutical deals this year have been between $1 billion and $10 billion.

The FDA approved Eli Lilly’s new weight-loss pill, setting up a fight with rival Novo Nordisk over the next front in the booming market

The drugmaker’s pill will take on a rival from Novo Nordisk in the booming multibillion-dollar obesity…

Years Before Prince Sultan Attack, U.S. Officials Sounded Alarm About Gulf Bases

The Saudi air base was struck by Iranian missiles and drones, damaging and destroying U.S. warplanes…

Iran Takes Aim at the Industries Behind the Gulf’s Pivot From Oil

The region’s diversification into tourism, metals and banking is giving Tehran a wider range of targets…

Stocks Advance on Hopes for Quick End to War

U.S. stocks rose, extending a “Hormuz Hope” rally from Tuesday that pushed the three major stock…

How a Tsunami Was Unleashed at 17,000 Feet, Shattering Lives Below

As warmer temperatures melt polar ice, a parallel danger lurks in high mountain areas where melting…

U.A.E. Wants to Force Hormuz Open and Is Willing to Join the Fight

The Gulf state has begun a campaign to persuade the U.S. and allies in Europe and…

Kremlin Enters the Chat With Russia’s New Super-App

Max, a messaging and e-commerce platform, will offer everything from taxi-hailing services to electronic passport wallets.

Trump Raises NATO Withdrawal as Allies Push Back on Iran War

Rising tensions between the U.S. and Europeans are threatening to break up the alliance that has…

U.A.E. Is Revoking Visas, Stranding Iranian Residents Abroad in a Widening Crackdown

Ties that date back centuries are under heavy strain from Iran’s bombardments during the war.